Pharma Journalist -

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the risk of…
Read More...

Oncoheroes Biosciences Inc and Boehringer Ingelheim International GmbH have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound…
Read More...

SMi Reports: SMi’s  9th annual Biobanking Conference will take place at the Copthorne Tara Hotel, London, on the 25th – 26th September 2019. There is only two weeks left until the…
Read More...

Akari Therapeutics, a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement (C5) and/or leukotriene…
Read More...

Eisai Co., Ltd. and Biogen Inc. announced the decision to discontinue the Phase III clinical studies (MISSION AD1, AD2) on the investigational oral BACE (beta amyloid cleaving enzyme)…
Read More...

Castle Creek Pharmaceutical Holdings, Inc. announced it has reached an agreement to acquire Fibrocell Science, a cell and gene therapy company focused on transformational autologous…
Read More...

Vertex Pharmaceuticals Incorporated announced that eligible cystic fibrosis patients living in Scotland will now have access to ORKAMBI (lumacaftor/ivacaftor) and SYMKEVI…
Read More...

GlaxoSmithKline announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for use in children as young as six years old who are living with severe…
Read More...

Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Investigational Medicinal Product (IMP) and Wholesale Distribution…
Read More...

Aytu BioScience, a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, a specialty…
Read More...